Skip to main content
    D

    DarioHealth Corp (DRIO)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.15
    +0.00 (+0.00%)

    Market Cap: $12.98M

    Last updated: Nov 17, 2026 at 4:04 PM ET

    DarioHealth Corp (DRIO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    DarioHealth (DRIO) has a market cap of $12.98M and an enterprise value of $16.38M. Its share count is up 284.32% from a year earlier. It kept -159.85% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 26.22% above the market cap, as debt exceeds cash.

    Market Cap$12.98M
    Enterprise Value$16.38M
    Latest price (Nov 17, 2026)$1.15

    Key Dates

    The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 17, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 29.08% in the quarter ended Sep 30, 2026.

    Shares Outstanding12.06M
    Shares Change (YoY)+284.32%
    Shares Change (QoQ)+29.08%

    Valuation Ratios

    Sales and book value multiples are 0.7x and 0.2x. Its year-end P/S ranged from 1.7x to 18.3x from 2016 to 2025.

    P/S Ratio0.7x
    Forward P/S0.6x
    P/B Ratio0.2x

    Valuation history and multiples

    Price Statistics

    The stock is down 90.20% over 52 weeks and trades 75.94% below its 50-day average.

    Beta (1Y)0.16
    52-Week Change-90.20%
    1-Month Change-74.39%
    3-Month Change-83.94%
    6-Month Change-85.98%
    5-Year Change-99.08%
    10-Year Change-99.77%
    Total Return (1Y)-90.20%
    Total Return (3Y CAGR)-63.57%
    Total Return (5Y CAGR)-67.57%
    Return vs SPY (1Y)-102.86%
    Max Drawdown (1Y)-91.79%
    Max Drawdown (3Y)-97.75%
    Sharpe Ratio (1Y)-2.78
    Correlation with SPY (1Y)0.02
    50-Day Average$4.78
    200-Day Average$7.19
    52-Week Range$1.09 to $14.77
    RSI (14 Days)17.6
    Average Volume (20 Days)88.35K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.20x current liabilities, and total debt is 0.44x shareholder equity.

    Current Ratio4.20x
    Quick Ratio3.81x
    Debt / Equity0.44x

    Returns and Efficiency

    Return on invested capital is -22.28% over the last 12 months, against a 5-year average of -59.50%.

    Return on Equity (ROE)-47.78%
    Return on Assets (ROA)-30.29%
    Return on Invested Capital (ROIC)-22.28%
    Return on Capital Employed (ROCE)-28.00%
    ROE (5Y Average)-78.09%
    ROA (5Y Average)-52.77%
    ROIC (5Y Average)-59.50%
    Asset Turnover0.19x
    Inventory Turnover2.47x
    Receivables Turnover14.21x
    Cash Conversion Cycle-159 days

    Scores

    DRIO has an Altman Z-Score of -6.08, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-6.08
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $21.30M over the last 12 months is down 13.86% from the 12 months before.

    Revenue$21.30M
    Revenue Growth (YoY)-13.86%
    Gross Profit$12.34M
    Operating Income-$30.39M
    Pretax Income-$31.90M
    Net Income-$34.05M
    EBITDA-$26.82M
    EBIT-$28.91M
    Reported EPS (TTM)-$3.30

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 63.39% of the $112.43M in total assets.

    Cash and Equivalents$27.84M
    Total Debt$31.25M
    Net Debt$3.40M
    Net Debt Per Share$0.28
    Working Capital$29.31M
    Shareholder Equity$71.27M
    Book Value Per Share$5.91
    Tangible Book Value-$684.00K
    Total Assets$112.43M
    Total Liabilities$41.16M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $122.00K of capital spending, operating cash flow left -$23.66M of free cash flow.

    Operating Cash Flow-$23.53M
    Capital Expenditures$122.00K
    Free Cash Flow-$23.66M
    FCF Per Share-$2.41
    Depreciation and Amortization$2.10M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -142.68%.

    Gross Margin57.93%
    Operating Margin-142.68%
    Pretax Margin-149.73%
    Net Margin-159.85%
    EBITDA Margin-125.87%
    EBIT Margin-135.72%
    FCF Margin-111.04%
    Gross Margin (5Y Average)37.87%

    Growth

    Revenue fell 6.84% a year over 3 years.

    Revenue Growth (3Y CAGR)-6.84%
    Revenue Growth (5Y CAGR)+24.17%

    Revenue and profit by year

    Dividends and Yields

    DRIO does not pay a dividend. Its free cash flow yield is -170.56%.

    FCF Yield-170.56%
    Buyback Yield0.14%
    Shareholder Yield0.14%

    Stock Splits

    The last split was a 1-for-20 reverse split on Aug 28, 2025.

    Last Split DateAug 28, 2025
    Split TypeReverse split
    Split Ratio1:20

    Analyst Forecast

    Consensus estimates put revenue growth at 14.09% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+14.09%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About DRIO

    What is DRIO's market cap?

    DarioHealth has a market cap of $12.98M. Its enterprise value, which adds debt and subtracts cash, is $16.38M.

    How many shares of DRIO are outstanding?

    DarioHealth has 12.06M shares outstanding. The count is up 284.32% from a year earlier.

    Does DRIO pay a dividend?

    No. DarioHealth does not pay a dividend.

    How much debt does DRIO have?

    DarioHealth has $31.25M of total debt and $27.84M of cash and equivalents, a net debt position of $3.40M.